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Francis L Weng1,2*, Diane R Brown2, John D Peipert3, Bart Holland2,4 and Amy D Waterman3Abstract
Background: The best treatment option for end-stage renal disease is usually a transplant, preferably a live donor
kidney transplant (LDKT). The most effective ways to educate kidney transplant candidates about the risks, benefits,
and process of LDKT remain unknown.
Methods/design: We report the protocol of the Enhancing Living Donor Kidney Transplant Education (ELITE)
Study, a cluster randomized trial of an educational intervention to be implemented during initial transplant
evaluation at a large, suburban U.S. transplant center. Five hundred potential transplant candidates are cluster
randomized (by date of visit) to receive either: (1) standard-of-care (“usual”) transplant education, or (2) intensive
education that is based upon the Explore Transplant series of educational materials. Intensive transplant education
includes viewing an educational video about LDKT, receiving print education, and meeting with a transplant
educator. The primary outcome consists of knowledge of the benefits, risks, and process of LDKT, assessed one
week after the transplant evaluation. As a secondary outcome, knowledge and understanding of LDKT are assessed
3 months after the evaluation. Additional secondary outcomes, assessed one week and 3 months after the
evaluation, include readiness, self-efficacy, and decisional balance regarding transplant and LDKT, with differences
assessed by race. Although the unit of randomization is the date of the transplant evaluation visit, the unit of
analysis will be the individual potential transplant candidate.
Discussion: The ELITE Study will help to determine how education in a transplant center can best be designed to
help Black and non-Black patients learn about the option of LDKT.
Trial registration: Clinicaltrials.gov number NCT01261910.
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Cluster randomizationBackground
For patients with end-stage renal disease (ESRD), a kidney
transplant from a living donor is usually the best treat-
ment option. Living donor kidney transplants (LDKTs)
and deceased donor kidney transplants (DDKTs) both im-
prove ESRD patients’ survival and quality of life [1-4].* Correspondence: fweng@barnabashealth.org
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reproduction in any medium, provided the orLDKT, however, offers several potential advantages com-
pared to DDKT. LDKT allows transplant candidates to by-
pass the long DDKT waitlist, minimizes (and enables
avoidance of) chronic dialysis and its associated morbid-
ities [5], can be scheduled for a time convenient for the
transplant recipient and living donor, and facilitates trans-
plant among sensitized transplant candidates (who are
often unable to otherwise receive a transplant) [6,7]. Fur-
thermore, LDKT offers substantially better patient and
allograft outcomes than DDKT [8]. For many patients,td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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while awaiting a DDKT [9,10].
Unfortunately, despite the many advantages of LDKT,
Blacks with ESRD are less likely to receive LDKTs, com-
pared to non-Blacks [11-13]. In 2011, Blacks made up
33.2% of the waiting list for DDKTs and received 32.2%
of all DDKTs but received only 14.0% of all LDKTs [14].
This striking racial disparity stems from multiple factors
and barriers [15,16]. One such barrier may be a need for
more education and knowledge of LDKT and living do-
nation, given the desire by Blacks (and non-Blacks) for
such education and knowledge [17-19].
In addition to its advantages, LDKT has short-term
and possibly long-term risks for living donors [20]. The
short-term, peri-operative risks of donor nephrectomy
(e.g. bleeding, infections, pneumothorax, and venous
thromboembolism) resemble the risks of similar opera-
tions. Peri-operative death is very rare, occurring in ap-
proximately 0.03% of nephrectomies [21-23]. Long-term,
living kidney donors may have increased risks of hyper-
tension [24], proteinuria [25], and chronic kidney disease
(CKD) [26,27]. These risks may be increased among do-
nors who are Black, versus non-Black [23,26,27]. Despite
these possible risks, living kidney donors appear to have
the same rates of death and ESRD as the general popula-
tion [10,23,28-30].
Given the substantial benefits of LDKT for the recipi-
ent and the possible long-term risks of nephrectomy for
the living donor, kidney transplant candidates (and their
living donors) should make informed choices regarding
whether to pursue LDKT. Better education may increase
CKD patients’ knowledge of LDKT. Among CKD pa-
tients, increased knowledge of LDKT has been associ-
ated with increased comfort in discussing LDKT with
others and decreased concerns about live kidney dona-
tion [17].
The best source for accurate information about the
process, risks, and benefits of LDKT is likely the local
transplant center [31]. In the U.S., the Centers for Medi-
care and Medicaid Services has currently approved ap-
proximately 235 centers to perform kidney transplants
[32]. Approved transplant centers must educate and in-
form patients about transplantation [33], but these cen-
ters vary greatly in how they deliver this education [34].
Each center educates patients using its own combination
of print materials, videos, and group or one-on-one dis-
cussions with transplant personnel [34]. The best ways
to provide education about LDKT remain unknown, so
studies of potentially effective and replicable approaches
to LDKT education are needed.
Therefore, we describe the protocol for the Enhancing
Living Donor Kidney Transplant Education (ELITE)
study, a cluster randomized clinical trial designed to test
the impact of an educational intervention upon potentialtransplant candidates’ knowledge of LDKT. As mandated
by the funding source, the federal Health Resources and
Services Administration (HRSA), and grant program, the
primary outcome of this study is knowledge of the bene-
fits, risks, and process of live donor kidney transplant,
rather than rates of actual LDKT [35].
Methods/design
Study design summary
The ELITE study is a single-center, cluster randomized
[36,37], parallel group clinical trial designed to test the
effectiveness of an educational intervention [38] upon
transplant candidates’ knowledge of LDKT (see Figure 1
for flow diagram and Additional file 1 for CONSORT
2010 checklist of information to include when reporting
a cluster randomised trial). All study procedures were
approved by the Institutional Review Boards at both
Saint Barnabas Medical Center (SBMC, protocol number
2009–53) and the University of Medicine and Dentistry
of New Jersey (protocol number 0120100096).
Target population, setting, and inclusion/
exclusion criteria
The targeted patient population consists of Black and
non-Black persons with CKD who underwent evaluation
for kidney transplant (potential transplant candidates) at
Saint Barnabas Medical Center, a suburban transplant
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Jersey, in the northeastern United States. We use the term
“potential transplant candidates” to describe CKD patients
who are referred for transplant and appear for evaluation
by the transplant center. “Transplant candidates”, also
known as “listed” or “actual” transplant candidates, are po-
tential transplant candidates who are deemed suitable for
transplant, made active on the waiting list for a DDKT,
and able to receive a LDKT if they have a living donor.
During the two years prior to the ELITE study, Saint
Barnabas Medical Center evaluated approximately 700 po-
tential transplant candidates per year.
Persons are eligible for the ELITE study if they meet
the following inclusion criteria: (1) appear for initial kid-
ney transplant evaluation at Saint Barnabas Medical
Center; (2) are 18 years of age or older; (3) are able to
provide informed consent; and (4) are able to speak,
hear, and understand English. We exclude persons from
the ELITE study if they: (1) have significant neurocog-
nitive disability that would prevent participants from
understanding the study or completing the question-
naires; (2) are unable to speak, hear, and understand
English; (3) are visually impaired and unable to complete
self-administered case report form; and (4) have a self-
described unwillingness or inability to complete phone
interviews.
Study aims
Our primary aim is to determine the effects of an educa-
tional intervention (intensive transplant education), ver-
sus standard-of-care (usual) transplant education, upon
transplant candidates’ knowledge of the benefits, risks,
and process of LDKT, assessed one week after transplant
evaluation.
As secondary aims, this study will also determine dif-
ferences in readiness, self-efficacy, and decisional bal-
ance regarding transplant at one week after transplant
evaluation, between patients who receive intensive, ver-
sus usual, transplant education. The study will also
examine how knowledge, readiness, self-efficacy, and de-
cisional balance change between one week and three
months, in patients who receive intensive, versus usual,
transplant education. Finally, the study will also deter-
mine how known barriers to LDKT, including Black
race, less prior transplant education, and lower health
literacy, act alone and in combination with the educa-
tional interventions to affect patients’ level of knowledge
at one week and three months.
Randomization
Randomization procedures and rationale for
cluster randomization
All the potential transplant candidates on a given evalu-
ation day are cluster randomized to either standard-of-care transplant education (“usual” care or control, Arm
1) or intensive transplant education (experimental, Arm
2). At Saint Barnabas Medical Center, transplant education
generally occurs thrice weekly, on Tuesdays, Wednesdays,
and Fridays. Immediately before each week’s evaluations
begin, we randomize each week’s evaluation days, using a
computer-generated random number. Therefore, the unit
of randomization will be the date of the transplant evalu-
ation. As with most educational interventions, we are un-
able to blind or mask study personnel and participants
regarding treatment allocation groups (usual care vs. in-
tensive education). The study arm is unknown, however,
at the time the potential transplant candidates scheduled
their evaluations.
We chose cluster randomization to minimize contam-
ination between study arms [39] as well as for practical
administrative reasons. If we randomize at the level of
the individual patient (potential transplant candidate),
then on a given evaluation date, some potential trans-
plant candidates will receive usual care (standard-of-care
education), while others will receive intensive education
(the intervention). Because potential candidates often
talk and share information with each other throughout
the evaluation day, randomization at the level of the indi-
vidual patient will likely lead to significant contamination
between study arms. Cluster randomization minimizes
such contamination. In addition, by assigning all patients
on a given date to receive the same education (usual or
intensive), cluster randomization facilitates coordination
of the transplant evaluation with performance of this re-
search trial. Although the unit of randomization is the
date of the transplant evaluation, the unit of analysis will
be the individual potential transplant candidate.
Standard-of-care (usual) transplant education (Arm 1)
During their transplant evaluation day, potential transplant
candidates randomized to standard-of-care (usual) initial
education will receive the standard transplant education
and evaluation provided by SBMC. Family and friends are
encouraged to accompany the patient to the evaluation.
First, patients and their guests listen to and view a 90-
minute slide presentation given by one of our trained
transplant nurse coordinators. The presentation reviews:
 treatment options for chronic kidney disease,
including LDKT and DDKT;
 the kidney transplant evaluation process;
 how the deceased donor waiting list works;
 the types of LDKTs and DDKTs. These slides
succinctly review the benefits of LDKT, the workup
of potential living donors, the types of living kidney
donors, and alternative programs for LDKT;
 potential medical and psychosocial benefits and risks
of kidney transplantation
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 patients’ rights and responsibilities.
These topics must be included in the educational in-
formation provided to potential transplant candidates, as
mandated by the Centers for Medicare and Medicaid
Services [33].
After the presentation, potential transplant candidates
are evaluated in private offices by members of the trans-
plant team, including the transplant nurse coordinator,
social worker, nephrologist, dietician, and financial co-
ordinator. Potential transplant candidates meet separ-
ately with each transplant team member in a varying,
unsystematic order, based on the availability of the team
members. The research nurse or assistant also meets pri-
vately with each potential transplant candidate. Because
the order in which potential transplant candidates meet
with team members is unsystematic, the meeting between
the research staff and the patient may occur at any point
during the evaluation. The research staff member deter-
mines the patient’s eligibility for the study, obtains in-
formed consent, and administers the initial questionnaires.
The research nurse or assistant also sets an appointment
date and time, at approximately one week after the trans-
plant evaluation, for phone administration of follow-up
questionnaires measuring knowledge and other outcomes.
Intensive transplant education (experimental, Arm 2)
Potential transplant candidates who are cluster-randomized
to intensive initial education (Arm 2) undergo the same
education and evaluations as candidates in the usual educa-
tion group. Additionally, study participants in the intensive
education arm also undergo an intervention designed to in-
crease knowledge of LDKT. This intervention is directed
by the research nurse or assistant, who functions as a
Transplant Educator. The intervention is based upon mate-
rials from the Explore Transplant series of kidney trans-
plant education materials. When implemented in dialysis
units, Explore Transplant has been shown to increase dialy-
sis patients’ pursuit of DDKTand LDKT [40]. However, Ex-
plore Transplant has yet to be tested at a transplant center.
Our educational intervention consists of two parts,
both implemented on the day of the transplant evalu-
ation. First, study participants (together with any friends
and family who accompanied them) view a 25-minute
video, entitled “The experiences of living kidney donors”,
from the Explore Transplant series of kidney transplant
education materials [41,42]. This video, intended for po-
tential transplant candidates, discusses how living donors
came to their decision to donate; donors’ motivations and
what they learned; facts about the donor evaluation, sur-
gery, and recovery; risks to the living donors; and life after
donation. The learning objectives of the video are to en-
able the viewer to understand the evaluation, surgery, andrecovery process of living donors; learn possible risks that
living donors face and how often these risks occur; learn
the advantage of living donor kidneys versus deceased
donor kidneys; and learn ways family member and friends
can provide support to transplant candidates. The video
features the stories of actual living kidney donors and pre-
sents accurate medical facts about LDKT, presented by
medical professionals.
Second, after viewing the video, the study participants
meet privately with the trained Transplant Educator for
a fifteen-minute meeting to:
 Answer any questions that patients may have had,
based upon what they saw in the video;
 Explore with patients their reasons for wanting a
kidney transplant;
 Explore with patients their current situation with
CKD/ESRD;
 Examine how the patients’ CKD/ESRD affects their
family and friends;
 Answer any questions or concerns about transplant
that the patient has;
 Review a brochure from Explore Transplant, “Why
Kidney Patients Get Transplants/Why People
Donate Their Kidneys”;
 Review a fact sheet from Explore Transplant,
“Possible Risks to Living Donors”; and
 Review a fact sheet from Explore Transplant, “Living
Donors’ Evaluation, Surgery, and Recovery”.
Because the order in which potential transplant candi-
dates meet with team members is unsystematic, the
viewing of the video and meeting with the Transplant
Educator occur at any point during the transplant
evaluation.
Outcomes
Measurement timepoints
After the transplant evaluation, we measure knowledge,
readiness, self-efficacy, and decisional balance regarding
transplant (DDKT and LDKT) (Table 1). To measure
these characteristics, we administer telephone question-
naires to study participants at 1 week and 3 months after
the transplant evaluation. These questionnaires are ad-
ministered by research personnel who are not involved
in participant recruitment and who are blinded to the
study arm.
We are unable to measure study participants’ “baseline”
knowledge, readiness, self-efficacy, and decisional balance
regarding transplant, prior to starting the evaluation. This
inability stems from human subjects IRB restrictions that
prevent us from administering questionnaires by tele-
phone to persons who have not provided written informed
consent. In addition, on the day of the actual transplant
Table 1 Data collection
Day of evaluation 1 week later 3 months later 12 months later
Transplant information
Demographic and medical characteristics X
Prior discussions with physicians regarding transplant X
Prior education regarding transplant X
Willingness to accept LDKT X X
Actions to find living donors X X
Placement on DDKT waiting list for transplant (and reasons for non-listing) X
Mortality status X
Health literacy
Newest Vital Sign X
Single-item questions regarding use of surrogate reader and confidence
with filling out forms
X
Outcomes
Knowledge of transplant X X
Readiness to pursue transplant X X
Self-efficacy regarding transplant X X
Decisional balance regarding transplant X X
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from up to six transplant candidates, prior to the delivery
of any actual education, is also infeasible. Therefore, due
to human subjects limitations and practical concerns, we
are unable to obtain baseline measures (of knowledge,
readiness, self-efficacy, and decisional balance regarding
transpland and LDKT) prior to the start of usual or inten-
sive transplant education.
Primary outcome: knowledge of LDKT at 1 week after the
transplant evaluation
The primary study outcome is knowledge of the benefits,
risks, and process of LDKT, one week after the transplant
evaluation. Knowledge is measured using a 20-item ques-
tionnaire that contains 12 true-false and 8 multiple-choice
questions. This questionnaire is being used in other stud-
ies of LDKT and live kidney donation [42].
Secondary outcome: change in knowledge of LDKT at 3
months after the transplant evaluation
As a secondary outcome, we also assess change in know-
ledge of LDKT three months after the transplant evaluation.
Knowledge at three months is assessed using the same 20-
item questionnaire that we use at 1 week after the trans-
plant evaluation. LDKT knowledge “difference” scores will
be calculated by subtracting the 1 week post-baseline LDKT
knowledge scores from the 3 month post-baseline scores.
Other secondary outcomes
The other secondary outcomes include: (1) readiness to
pursue transplant and LDKT; (2) self-efficacy regardingtransplant and LDKT; and (3) decisional balance regarding
transplant and LDKT. These outcomes are also assessed
by phone-administered questionnaires, at one week and
three months post-evaluation. We will calculate self-
efficacy and decisional balance “difference” scores by sub-
tracting the 1 week post-baseline LDKT knowledge scores
from the 3 month post-baseline scores.
Readiness to pursue DDKT and LDKT
Readiness to pursue DDKT and LDKT are assessed using
the Stages of Change, from Prochaska’s Transtheoretical
Model [43,44]. For readiness to pursue DDKT, study partic-
ipants choose whether there are in the Pre-Contemplation,
Contemplation, Preparation, Action, or Maintenance stages
(see Table 2 for descriptions of stages). Similarly, for readi-
ness to pursue LDKT, study participants self-identify
whether they are in Pre-Contemplation, Contemplation,
Preparation, or Action (Table 2).
To further assess readiness to pursue LDKT, we also as-
sess Stage of Change regarding (1) asking a family or friend
to consider living donation and (2) accepting an offer of a
live donor kidney (among the subset of study participants
who had received an offer of a live donor kidney).
Self-efficacy (transplant confidence)
We measure participants’ self-efficacy (transplant confi-
dence), which reflects their confidence that they can en-
act and sustain a behavior change [45] (in this case, the
behavior change is receipt of a transplant or LDKT). We
assess study participants’ confidence in their ability to
pursue transplant and LDKT in difficult situations. For
Table 2 Statements that describe readiness (Stage of Change) for deceased donor and living donor kidney transplant
Stage of Change Readiness for deceased donor kidney transplant Readiness for live donor kidney transplant
Pre-contemplation “I am NOT considering in the next 6 months getting
a deceased donor transplant”
“I am NOT considering in the next 6 months getting a living
donor transplant”
Contemplation “I am considering taking actions in the next 6 months
to get a deceased donor transplant”
“I am considering taking actions in the next 6 months to get
a living donor transplant”
Preparation “I am preparing to take actions in the next 30 days to
get a deceased donor transplant”
“I am preparing to take actions in the next 30 days to get
a living donor transplant”
Action “I am undergoing transplant evaluation to get a deceased
donor transplant”
“I am taking actions to get a living donor transplant”
Maintenance “I am listed and waiting to get a deceased donor transplant” None
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that you could get a transplant even if…” for eight items
and scenarios, such as “…your friends and family were
unsupportive of you getting a transplant”. Similarly, six
self-efficacy questions focus upon LDKT and ask “How
confident are you that you could get a living donor
transplant even if…”, followed by items and scenarios
such as “…you don’t know anyone who might be a living
donor for you”. Responses are on a 5-point Likert scale
from “Not at all confident” to “Completely confident”.
Decisional balance (Pros and Cons of DDKT and LDKT)
Decisional balance measures how patients are weighing
the advantages and disadvantages (pros and cons) of
transplant. We ask patients to rate the importance of
possible positive and negative items related to patients’
decisions about DDKT and LDKT. We include 12 items
regarding transplant in general and 12 items regarding
LDKT. For each item, we ask, “How important is this
statement to your decision about transplant/living donor
transplant?” Sample statements include “I would live a
longer life with a transplant” (Pro of transplant) and “I
will feel guilty having someone donate to me” (Con of
LDKT). Responses are rated on a 5-point Likert scale
from “Not important” to “Extremely important”.
Other collected variables
Prior actions taken to learn about transplant
On the day of the transplant evaluation, we ask study par-
ticipants about prior actions they had taken to learn about
kidney transplant. These prior actions include: reading
brochures about kidney transplant, reading brochures
about LDKT, browsing Internet websites about kidney
transplant, watching television or videos about kidney
transplant, attending kidney disease support groups, talk-
ing to recipients of a kidney transplant, talking to doctors
and medical staff about transplant, and talking to family
and friends about transplant.
Health literacy
On the day of the transplant evaluation, we assess study
participants’ health literacy in two ways. First, we administerthe Newest Vital Sign (NVS), a validated in-person
measure of health literacy and numeracy [46]. The NVS
assesses functional health literacy and numeracy and is
scored from zero to six, with higher scores reflecting
better health literacy. Scores of zero to three suggest
limited health literacy [46].
Second, we use screening questions to inquire about
the participants’ ability to read, comprehend, and fill out
hospital forms [47,48]. These screening questions ask
the study participant (1) “How often do you have prob-
lems learning about your medical condition because of
difficulty understanding written information?” (always,
often, sometimes, occasionally, or never); (2) “How often
do you have someone help you read hospital materials?”
(always, often, sometimes, occasionally, or never); and
(3) “How confident are you filling out medical forms by
yourself?” (extremely, quite a bit, somewhat, a little bit,
or not at all). These questions are effective in identifying
persons with limited health literacy [49].
Final follow-up
After the 1-week and 3-month telephone interviews, study
participants are followed for 12 months after their trans-
plant evaluation. At that point, based upon our medical
records, we determine whether the potential transplant
candidate is placed on the waiting list at our center (and if
not placed on the list, then the reason why) and whether
the study participant is alive or not.
Reimbursements and incentives for study participants
At the transplant evaluation, study participants receive
a $15 gift card to a local supermarket, gas station, or re-
tailer, as an incentive for study participation in either usual
or intensive education. After the completion of the 3-
month phone interview, a $10 gift card is mailed to the
study participants. No additional incentives were given for
completion of the 1-week or 3-month phone interviews.
Statistical analysis
The initial data analysis will be descriptive. Participants’
baseline variables (demographics, medical characteris-
tics, providers, etc.) will be described, using frequencies
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dian, range, standard deviation, and standard error of
the means for continuous variables (such as age). Scatter
plots of continuous variables and plots of means versus
levels of categorical variables will be examined to assess
bivariate relationships.
To determine whether randomization resulted in the
desired equal distributions in the arms of the study, we
will initially compare frequencies, means, and medians
for baseline variables across the two study arms (usual
vs. intensive education). Because the data are clustered
by evaluation session, all significance tests (bivariate and
multivariable statistical tests) will use generalized esti-
mating equations (GEE), which account for variance de-
termined by the cluster or “design effect” [50,51]. The
analysis will use a per-protocol analysis. As a sensitivity
analysis, we will perform an intent-to-treat analysis [52],
in which we use multiple imputation for data that are
missing. Multiple imputation allows intent-to-treat ana-
lysis by permitting inclusion in the analysis of all en-
rolled study participants [53].
Primary analysis
To evaluate the effects of the intensive versus usual
transplant education, upon LDKT knowledge one week
after the transplant evaluation, we will compare overall
knowledge scores between groups of candidates. These
knowledge scores will be calculated by totaling the num-
ber of correct responses (range 0–20). We will compare
knowledge scores between the usual vs. intensive educa-
tion groups using the two-sample t-test with GEE.
Randomization assignment (usual vs. intensive educa-
tion) will be the independent variable. To adjust for any
baseline characteristics that are unequally distributed be-
tween the two study arms, and to examine and control
for the effects of confounders and other covariates, we
will use multivariable linear regression models with GEE
to determine differences in knowledge between the two
study arms (usual vs. intensive education).
Secondary analyses
As a secondary outcome, we will also assess change in
transplant knowledge from 1 week post-evaluation to
approximately three months after the transplant evalu-
ation. In this analysis, the outcome will be measured as
“difference scores” (the 1 week knowledge score sub-
tracted from the three month knowledge scores) using
linear regression with GEE and adjusting for unequally
distributed baseline characteristics [54].
We will determine the impact of the study intervention
upon the other secondary outcomes: (1) readiness to pur-
sue transplant and LDKT at 1 week post-evaluation; (2)
self-efficacy regarding transplant and LDKT at 1 week
post-evaluation; (3) decisional balance regarding transplantand LDKT at 1 week post-evaluation; and (4) changes in
readiness, self-efficacy, and decisional balance regarding
transplant and LDKT, from 1 week to 3 months post-
evaluation. Self-efficacy, decisional balance, and change
in self-efficacy and decisional balance are measured on a
continuous scale, so they will also be analyzed with linear
regression with GEE. Readiness to pursue transplant and
LDKT will be analyzed as dichotomous outcomes, where
the probability of patients being in Action or Maintenance
vs. the probability of being in Pre-contemplation, Contem-
plation, or Preparation will be modeled with logistic regres-
sion with GEE. The tests for all secondary outcomes will
also be adjusted for any unbalanced baseline characteristics.
Finally, to examine how key barriers to LDKT work
alone and in combination with our intervention to impact
LDKT knowledge, we will test the independent effects of
race, previous actions taken to learn about transplant, and
health literacy on knowledge at 1 week post-baseline. We
will also test whether these variables interact with the
intervention to effect knowledge of LDKT. We will model
knowledge of LDKT as the dependent variable using mul-
tivariable linear regression models with GEE. To fit the
models, we will use forward selection procedures where
independent variables that are univariately significant at
P < 0.20 will be eligible for inclusion in the multivariable
model. Those variables significant at P < 0.05 in the multi-
variable models will be retained [55].
Power and sample size calculations
Our primary analysis will determine whether the study
intervention is associated with increased knowledge of
LDKT, one week after the transplant evaluation. Because
the randomization of patients is clustered by evaluation
date, sample size and power calculations for testing the
effect of the intervention must be based on the number
of evaluation days randomized to each condition, the
number of patients per evaluation day, the expected
intra-class correlation (ICC) among patients within a
cluster (ICC indicates within-group similarity on the
outcome), and the estimated difference between condi-
tions in, and variability of, transplant knowledge scores.
Based on previous research [40], we estimate that pa-
tients in the intervention arm will have 10-20% higher
transplant knowledge at 1 week post-baseline than pa-
tients in the standard-of-care arm. Assuming a conserva-
tive ICC of 0.4, we calculated that with 250 patients in
each of the two study arms from approximately 100
evaluation days per study arm (2–3 patients per evalu-
ation day), a two-sample t-test with type 1 error of 0.05
would have at least 95% power to detect a 10-20% differ-
ence in knowledge scores. In summary, to have sufficient
power to detect differences in the primary and secondary
outcomes, this study should include 250 patients in each
education condition at 1 week post-evaluation.
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We designed the ELITE study to determine whether an
educational intervention, implemented on the day of the
transplant evaluation at the transplant center, increases
knowledge of LDKT among potential transplant candi-
dates, assessed one week and 3 months after the evalu-
ation. Additional secondary outcomes include readiness,
self-efficacy, and decisional balance regarding transplant-
ation and LDKT, assessed one week and 3 months after
the evaluation. We also will compare the effectiveness of
the different educational interventions for Black and
non-Black patients and patients of varying levels of
health literacy.
This study is notable for testing an intervention that is
physically delivered at the transplant center, in a method
consistent with standard clinical care. If effective, more
intensive transplant education could be replicated and
easily incorporated into transplant evaluations in the ap-
proximately 235 transplant centers nationwide. Surpris-
ingly, few interventions have targeted CKD patients being
evaluated at the transplant center [42,56]. Instead, most
prior interventions have targeted CKD patients in ne-
phrologists’ offices [57,58], dialysis units [59,60], and pa-
tients’ homes [56,61]. By bringing together CKD patients
who have some preexisting interest in transplant, the
transplant evaluation, offers an opportunity to efficiently
and effectively educate these patients about LDKT.
Our study design has several potential limitations. Our
educational intervention is a relatively brief, one-time
event that occurs solely at the transplant evaluation.
Typically, the study participants in the intensive educa-
tion arm will spend less than one hour watching videos
and meeting with the Transplant Educator. An interven-
tion that includes additional education sessions (e.g.
after the transplant evaluation) may be more effective,
albeit less practical. In addition, all study participants in
the intervention arm receive the same intervention. If
we were able to measure study participants’ knowledge
and interest in LDKT prior to the transplant evaluation,
then we could tailor the intervention for each partici-
pant’s level of readiness.
In conclusion, the results of the ELITE study have the
potential to guide clinical care and patient education in
kidney transplant centers. Studies of behavioral and edu-
cational interventions implemented during the trans-
plant evaluation at the transplant center will enable the
transplant community to determine the best ways to
educate the CKD population regarding transplant.Additional file
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